AI has advanced from pilot programs into real biopharma workflows. But has it lived up to the hype? Drawing from an expert call with Dr. Paul Agapow, former director of data science at GSK, this report dissects whether AI is on track to make drug development faster, cheaper, and more successful. Learn how AI is reshaping drug development in real time, turning AI execution into a key competitive differentiator.
AI in Drug Development 2026: From Experimentation to Execution
About the Authors
Sara Mallatt, Director of Healthcare Research
Sara has more than 18 years of experience generating sell-side research content across a variety of industries. Prior to joining AlphaSense, Sara held leadership positions at OTR Global, a leading channel research firm, most recently as Director of Healthcare Research. Sara holds a bachelor’s degree in journalism and a master’s in industrial engineering. She works from her home in Missoula, Montana.
Sean Carmichael
Sean is a Business & Finance Editor at AlphaSense, specializing in sector-specific content production. Previously, he spent nearly a decade in various roles across financial services, where he was responsible for equity research and content generation geared toward institutional investors.
Explore more
EMEA Outlook 2026: Navigating Inflation, Manufacturing Shifts and AI Adoption
The extent to which EMEA economies can tame inflation, manage weakness in the auto sector, and harness AI for growth will be key to their economic prosperity in the months to come. In this report, we explore how these themes will impact EMEA in the second half of 2026.
Top AI Use Cases for Life Sciences Market Intelligence
Across life sciences functions, platforms like AlphaSense are streamlining the entire decision cycle. This report covers the top AI use cases that have transformed how the industry’s leading teams reach defensible answers.
Mid-Year AI Checkpoint: The Shift from Wow to Work
The first half of 2026 marked a turning point for AI. The focus shifted away from breakthrough demos to the harder questions of deployment, integration, and real-world impact. As AI became more deeply embedded in products, workflows, and business operations, organizations faced new questions around measurement, governance, workforce impact, trust, and control.
Transform intelligence
into advantage
Develop bold strategies, seize opportunities, and lead with clarity and confidence.